CAS: 52093-21-7; (2R,3R,4R,5R)-2-(((1S,2S,3R,4S,6R)-4,6-Diamino-3-(((2R,3R,6S)-3-Amino-6-((Methylamino)Methyl)Tetrahydro-2H-Pyran-2-yl)Oxy)-2-Hydroxycyclohexyl)Oxy)-5-Methyl-4-(Methylamino)Tetrahydro-2H-Pyran-3,5-Diol

该化合物是主要用于抗菌性特性的微小球菌抗生素,主要用于抗菌性的抗生素,其来源是细菌的基因,微米菌菌菌的发酵;微米菌针对各种小阴性细菌和某些小乳性细菌,其活动种类繁多,使其能有效治疗这些病原体造成的感染;行动机制涉及对细菌性脊髓灰质炎有约束力,抑制蛋白合成,最终导致细菌细胞死亡;这种化合物经常用于临床环境治疗严重感染,特别是抗菌株引起的感染;在物理特性方面,微米诺菌素通常是白对非白色粉末的白,可溶于水中,有助于其注射方式的施用;然而,同其他微微粒生物表面生物表面一样,它可能具有潜在的肾毒性和毒性副作用,因此需要在治疗期间进行仔细监测.总的来说,微米菌是治疗系统抗菌体感染的一种宝贵的抗生素,特别是在其他情况无效的情况下.

结构式图片

上下游产品

CAS号32385-11-8 西索米星

合成工艺路线路线简述

    📜西索米星 以 水 作为反应溶剂,化学反应 20.0H,反应生成 庆大霉素,小诺霉素
    参考文献:Biotransformation Of Sisomicin And Verdamicin Bymicromonospora Sagamiensis
    标题:Biotransformation Of Sisomicin And Verdamicin Bymicromonospora Sagamiensis
    摘要:研究发现,一种 2-脱氧链霉胺白痴化突变体(micromonospora Sagamiensis)的静止细胞能将西索米星转化为庆大霉素 C1A 和沙加米星.通过离子交换和碳柱色谱相结合的方法分离了生物转化产物,并进行了适当的鉴定.在转化产物中没有检测到抗生素 G-52(6'-N-甲基西索米星).庆大霉素 C1A 在生物转化的早期形成,随后形成了沙加米星.西索米星可能首先发生(4',5')还原,然后是 6'-N-甲基化.通过使用类似的程序,证明了维达米星转化为庆大霉素 C2A(庆大霉素 C2 的 6'-C外嵌体),C2,然后是 C1.碳液相色谱法清楚地分离了庆大霉素 C2A,C2 和维达米星.在这一生物转化过程中,首先发生的是维达米星的(4',5')还原反应,然后是 6'-C-表聚反应,最后是 6'-N-甲基化反应.与萨加米菌相反,锡安菌 Nrrl5466 和伊代菌 Nrrl3292 不具有任何可检测到的西索米星或维达米星(4',5')还原活性.另外,Nrrl5466 将西索米星转化为抗生素 G-52,将维达米星转化为一种新的抗生素 Vf3-1.根据色谱和质谱数据,抗生素 Vf3-1 被认为是 6'-N-甲基氟达米星.讨论了这些发现对相思豆菌中沙加米星生物合成的影响.
    DOI:10.1080/00021369.1982.10865090

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-8147805-B2
    优先权日:2005-01-05
    标题:Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
    发明人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND
    权利人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND; UNIV T EXAS SYSTEM BOARD OF REGENTS
    摘要:Compositions and methods for dual imaging and for dual chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns compounds comprising the structure X 1 —Y—X 2 , wherein Y comprises two or more carbohydrate residues covalently attached to one another, X 1 and X 2 are diagnostic or therapeutic moieties covalently attached to Y, provided that when Y does not comprise a glucosamine residue, X 1 and X 2 are diagnostic moieties. The present invention also concerns methods of synthesis of these compounds, application of such compounds for dual imaging and treatment of hyperproliferative disease, and kits for preparing a radiolabeled therapeutic or diagnostic compound.

    专利号:US-2015158809-A9
    优先权日:2013-02-26
    标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
    发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
    权利人:XENOPORT INC
    摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

    专利号:WO-2009094569-A2
    优先权日:2008-01-25
    标 题:Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates

    专利号:US-2005222431-A1
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bi S, Zhou H, Wu J, Sun X. Micronomicin/tobramycin binding with DNA: fluorescence studies using of ethidium bromide as a probe and molecular docking analysis. J Biomol Struct Dyn. 2018 Apr
    24:1-13. doi: 10.1080/07391102.2018.1461138. [Epub ahead of print] doi: 10.1016/j.chroma.2013.04.059. Epub 2013 Apr 27. doi: 10.1007/s11274-013-1261-0. Epub 2013 Jan 25. doi: 10.1016/j.jpba.2012.11.029. Epub 2012 Nov 27. Epub 2009 Sep 24.
    8: Sunada A, Ueda A, Inoue Y, Ohashi Y, Uno T, Kitagawa K, Hatano H, Shiota H, Asari S. [Comparison of minimum inhibitory concentration and postantibiotic effect of eyedrops on isolates in National Surveillance of Infectious Keratitis in Japan]. Nippon Ganka Gakkai Zasshi. 2006 Dec;110(12):973-83. Japanese. Chinese. Japanese. Chinese. Japanese.

    合成参考文献


    摘要:Japanese Journal of Antibiotics., 30(386), 1977 []
    摘要:Hara T, Nishikawa S, Miyazaki H, Ohguro Y. [Studies on the safety of KW-1062 (fifth report). A comparative study on the renal toxicity of KW-1062 and gentamicin in rats by ligh and electron microscopies (author's transl)]. Jpn J Antibiot. 1980 Jan;33(1):1–9.
    摘要:Akiyoshi M, Hara T. [Animal test for evaluation of ototoxicity and safety of KW-1062 (author's transl)]. Jpn J Antibiot. 1980 Feb;33(2):219–26.
    参考文献:10.1016/j.jpba.2012.11.029
    摘要:Yuan Y, Zhao X, Zhang M, Fan X, Hu C, Jin S, Van Schepdael A, Hoogmartens J, Adams E. Impurity profiling of micronomicin sulfate injection by liquid chromatography–ion trap mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 2013 Mar;75():94–104. doi: 10.1016/j.jpba.2012.11.029.
    摘要:Mezzatesta ML, Pellegrino MB, D'Amico G, Uva M, Russo G, Nicoletti G. Preliminary results on the antibacterial activity of sagamicin towards microorganisms responsible for ocular pathology. J Chemother. 1989 Jul;1(4 Suppl):191–2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知